Treatment Registry
TR-0487 ActiveRecorded September 2026

Compounded semaglutide

Sold by Omzo · every compounded semaglutide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Recorded initial charges

First month

$179

first month, including required fees on record. The published monthly rate excludes one-time and annual fees; introductory and conditional rates may change. Some fee details are unverified or unpublished; this sum does not establish the full amount payable.

Medication · Semaglutide, starting price · recorded initial monthly payment$179

Added from the figures recorded below.

Price

TermPer monthCharged today
Semaglutide, starting price

“Semaglutide One simple injection per week. Starting at $179”

Per month$179Charged today$179
Price sources
Visit Omzo

We earn nothing from this link. It opens Omzo's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

StatesAll 50 states
CancellationIf a subscription is canceled after a charge has been processed: Cancellation will prevent future charges, but previously processed charges are non-refundable.

Not yet checked: pharmacy, prescriber, membership and consult fee.

Recorded from omzo.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2026 — The /weight-loss page is a JavaScript-rendered shell with no visible pricing text; the only GLP-1 prices found were the homepage's 'Starting at $179' (semaglutide) and 'Starting at $279' (tirzepatide) tiles, with no unit stated for the figure (assumed monthly, the site's evident convention). Omzo's fee statement says medication cost is bundled into the fees it collects ('Medication costs are included in the fees collected by Omzo'), consistent with these being real program prices rather than an excluded-medication membership. The state-coverage sentence is a stronger, unambiguous '50 states' claim than a vague 'nationwide' phrase, so it was recorded as all-50 rather than not-found.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0487
Medication category
compounded semaglutide
Readings
1

Related records

Other records from Omzo

All Omzo programs and terms

Compounded semaglutide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 372 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Omzo — compounded semaglutide (TR-0487). Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0487

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.